FinBoss.io
CSEN
  • Home
  • Crypto prices
  • Bitcoin on-chain
  • US macro
  • US stocks
  • Guides
  • How we make money
FinBoss.io
Home
Crypto prices
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Guides
How we make money
CSEN
Home
Stocks
UnitedHealth Group
UnitedHealth Group

UnitedHealth Group

UNHHealth care

Stock · Data from SEC EDGAR 13F · Held by 24 of 87 tracked investors

$418.09
▼ 1.62%
Famous investorshold 24buying 0selling 0
Price (USD)
$418.09
Market cap
$375B
P/E ratio
26.9
Tracked investors holding
24 of 87
Next earnings
–

UnitedHealth Group at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
67out of 100
  • Valuation54
  • Growth65
  • Profitability41
  • Quality57
  • Debt83
  • Stability100
In its favour
  • It earns 16 USD a year on every 100 USD of invested capital (ROE).
7D
+4.15%
1M
+11.49%
3M
-0.63%
YTD
+24.28%
1Y
+15.34%
3Y
-20.31%
5Y
-9.20%
Forward P/E
18
Dividend yield
2.18%
52-week low
$255.97
52-week high
$461.62

Chart UNH

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

24
SM
Samantha McLemore
Patient Capital Management
5.96%$181,951,987unchanged
CD
Chris Davis
Davis Advisors
2.28%$529,839,298▲ +2.2%
KF
Ken Fisher
Fisher Investments
1.12%$3,774,863,715▲ +73.4%
DY
Duan Yongping
H&H International Investment
0.87%$166,085,748▼ -33.6%
Šn
Švýcarská národní banka
Swiss National Bank
0.56%$1,064,029,841▼ -3.7%
Ns
Norský státní fond
Norges Bank
0.53%$5,293,868,088New position
CC
Chase Coleman
Tiger Global Management
0.52%$123,629,974▼ -15.1%
Čn
Česká národní banka
Česká národní banka
0.5%$94,670,299unchanged
SC
Steven Cohen
Point72 Asset Management
0.38%$345,328,264▲ +98.1%
GI
Generali Investments CEE
Generali Investments CEE
0.29%$6,164,623unchanged
CA
Cliff Asness
AQR Capital Management
0.25%$729,084,301▲ +79.8%
IE
Israel Englander
Millennium Management
0.24%$672,345,116▲ +19.2%
JS
Jim Simons
Renaissance Technologies
0.21%$152,541,984▼ -68.3%
PT
Paul Tudor Jones
Tudor Investment Corp
0.17%$125,597,152▼ -37.9%
TB
Tweedy Browne
Tweedy, Browne Company
0.13%$1,699,511▲ +11.5%
JG
Joel Greenblatt
Gotham Asset Management
0.08%$35,535,118▼ -0.7%
JY
Jeff Yass
Susquehanna International Group
0.06%$782,950,078▼ -40.8%
KG
Ken Griffin
Citadel Advisors
0.05%$442,293,080▼ -31%
LB
Louis Bacon
Moore Capital Management
0.03%$2,078,150New position
GS
George Soros
Soros Fund Management
0.02%$1,614,723▼ -94%
RD
Ray Dalio
Bridgewater Associates
0.01%$2,575,659New position
MG
Mario Gabelli
GAMCO Investors
0.01%$991,278▲ +8.6%
RB
Ron Baron
Baron Capital
0.01%$4,180,822New position
GG
Glenn Greenberg
Brave Warrior Advisors
0%$207,399New position

Frequently asked questions

How much is UnitedHealth Group (UNH) stock?

UnitedHealth Group shares trade at $418.09, -1.62% over the last trading day. The price is delayed.

What is the market cap of UnitedHealth Group?

The market cap of UnitedHealth Group is about $375B and its price-to-earnings ratio (P/E) is 26.9.

Does UnitedHealth Group pay a dividend?

The dividend yield of UnitedHealth Group is 2.18% a year. The yield can change with the company's decisions.

How has UnitedHealth Group stock performed over the last year?

The UnitedHealth Group share price changed by +15.34% over 12 months and by -9.20% over 5 years.

Which big investors hold UnitedHealth Group?

According to the latest 13F filings, 24 of 87 tracked investors hold UnitedHealth Group, for example Samantha McLemore, Chris Davis, Ken Fisher.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms (Czech)Privacy (Czech)Cookies (Czech)

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

✓
  • ✓It could repay its net debt from free cash flow in 1.7 years.
  • ✓Revenue grew 11.4% a year over 3 years.
  • ✓It pays a 2.2% dividend, which takes 58% of earnings.
  • What to watch
    • !Out of 100 USD of revenue, only 3.5 USD is left as net profit.

    The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

    Is the stock expensive?

    Reasonably priced

    For 1 USD of annual earnings you pay 26.9 USD. Based on next year's estimates 18.0 USD.

    P/E
    26.9×
    P/S
    0.8×
    EV/EBITDA
    14.7×

    Is the company growing?

    Growing
    22
    23
    24
    25

    Revenue over 3 years grew 11.4% a year. Last year -0.4%.

    Does it make money?

    Weak
    • Cost of sales 81
    • Research 0.0
    • Operations and selling 14.3
    • Taxes and other 1.5
    • Net profit 2.7

    Out of 100 USD of revenue, 2.7 USD is left as net profit.

    Is it financially healthy?

    Yes
    Cash
    28.5B USD
    Debt
    74.3B USD
    Free CF
    26.5B USD

    It could repay its net debt from free cash flow in 1.7 years.

    Does it pay a dividend?

    Pays
    Yield
    2.18%
    Of earnings
    58%

    Over a year you receive roughly 2.18% of the price per share. The payout is manageable for the company. It has raised the dividend for 9 years in a row.

    What do analysts expect?

    Buy
    Average target
    478.12 USD
    Vs price
    +14%

    25 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    24 of 87

    Among the tracked investors, Samantha McLemore, Chris Davis, Ken Fisher and others hold the stock according to 13F filings.

    Revenue and net profit (USD B)

    Margins (% of revenue)

    Free cash flow and capex (USD B)

    Cash and debt (USD B)

    Earnings per share (EPS, USD)

    Latest quarters (USD B)

    Dividend per share by year (USD)

    * the year has not ended yet. Source: Yahoo Finance.

    Ratios

    P/E
    26.9×
    Forward P/E
    18.0×
    P/B
    3.6×
    P/S
    0.8×
    PEG
    1.08
    EV/EBITDA
    14.7×
    Gross margin
    20.0%
    Operating margin
    5.8%
    Net margin
    3.5%
    ROE
    15.8%
    ROA
    5.2%
    Debt / equity
    0.7×
    Current ratio
    0.7×
    Revenue growth
    -0.4%
    Earnings growth
    75.9%
    Beta
    0.62
    Dividend
    2.18%
    Payout ratio
    58%